515 6. Complicanze tardive Bibliografia 1. Na KS, Yoo YS, Mok JW, Lee JW, Joo CK. Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. novembre 2015;50(11):1459–64. 2. Murray J, Stringer J, Hutt D. Graft-Versus-Host Disease (GvHD). In: Kenyon M, Babic A, curatori. The European Blood and Marrow Transplantation Textbook for Nurses [Internet]. Cham: Springer International Publishing; 2018 [citato 10 agosto 2022]. pag. 221–51. Disponibile su: http://link.springer.com/10.1007/978-3-31950026-3_11 3. Inamoto Y, Valdés-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, et al. Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working . Biol Blood Marrow Transplant. 2019;25(2):e46– 54. 4. for the Infectious Diseases Working Party EBMT, Styczyński J, Tridello G, Koster L, Iacobelli S, van Biezen A, et al. Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors. Bone Marrow Transplant. gennaio 2020;55(1):126–36. 5. Wolff D, Radojcic V, Lafyatis R, Cinar R, Rosenstein RK, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report. Transplant Cell Ther. ottobre 2021;27(10):817–35. 6. Flowers MED, Martin PJ. How we treat chronic graft-versushost disease. Blood. 22 gennaio 2015;125(4):606–15. 7. Carreno-Galeano JT, Dohlman TH, Kim S, Yin J, Dana R. A Review of Ocular Graft-versus-Host Disease: Pathophysiology, Clinical Presentation and Management. Ocul Immunol Inflamm. 18 agosto 2021;29(6):1190–9. 8. Shikari H, Amparo F, Saboo U, Dana R. Onset of Ocular GraftVersus-Host Disease Symptoms After Allogeneic Hematopoietic Stem Cell Transplantation. Cornea. marzo 2015;34(3):243–7. 9. Townley JR, Dana R, Jacobs DS. Keratoconjunctivitis Sicca Manifestations in Ocular Graft Versus Host Disease: Pathogenesis, Presentation, Prevention, and Treatment. Semin Ophthalmol. settembre 2011;26(4–5):251–60. 10. Nassar A, Tabbara KF, Aljurf M. Ocular manifestations of graftversus-host disease. Saudi J Ophthalmol. luglio 2013;27(3):215– 22. 11. Munir SZ, Aylward J. A Review of Ocular Graft-Versus-Host Disease. Optom Vis Sci. maggio 2017;94(5):545–55. 12. Giannaccare G, Bonifazi F, Sessa M, Dan E, Arpinati M, Fresina M, et al. Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: imRingraziamenti Dott. F. Zallio e Dott.ssa S. Butera, SCDU Ematologia, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italia plication for daily clinical practice. Eye. ottobre 2017;31(10):1417– 26. 13. Wang JCC, Teichman JC, Mustafa M, O’Donnell H, Broady R, Yeung SN. Risk factors for the development of ocular graftversus-host disease (GVHD) dry eye syndrome in patients with chronic GVHD. Br J Ophthalmol. novembre 2015;99(11):1514–8. 14. Cooke KR, Luznik L, Sarantopoulos S, Hakim FT, Jagasia M, Fowler DH, et al. The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. febbraio 2017;23(2):211–34. 15. Kezic JM, Wiffen S, Degli-Esposti MP. Keeping an ‘eye’ on ocular GVHD. Keep ‘eye’ Ocul GVHD. 19 settembre 2021;Clin Exp Optom .(105(2)):135-142. 16. Blecha C, Wolff D, Holler B, Holler E, Weber D, Vogt R, et al. Verification of the new grading scale for ocular chronic graftversus-host disease developed by the German-Austrian-Swiss consensus conference on chronic GVHD. Ann Hematol. febbraio 2016;95(3):493–9. 17. Giaccone L, Faraci DG, Butera S, Lia G, Di Vito C, Gabrielli G, et al. Biomarkers for acute and chronic graft versus host disease: state of the art. Expert Rev Hematol. 2 gennaio 2021;14(1):79–96. 18. de Melo Franco R, Kron-Gray MM, De la Parra-Colin P, He Y, Musch DC, Mian SI, et al. Outcomes of Cataract Surgery in GraftVersus-Host Disease. Cornea. maggio 2015;34(5):506–11. 19. Jacobs R, Tran U, Chen H, Kassim A, Engelhardt BG, Greer JP, et al. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant. novembre 2012;47(11):1470–3. 20. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant. dicembre 2005;11(12):945–56. 21. Pavletic SZ, Lee SJ, Socie G, Vogelsang G. Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplant. 1 novembre 2006;38(10):645–51. 22. Couriel D, Carpenter PA, Cutler C, Bola os-Meade J, Treister NS, Gea-Banacloche J, et al. Ancillary Therapy and Supportive Care of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant. aprile 2006;12(4):375–96. 23. Riemens A, te Boome LCJ, Kalinina Ayuso V, Kuiper JJW, Imhof SM, Lokhorst HM, et al. Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study. Acta Ophthalmol (Copenh). febbraio 2014;92(1):82–7.
RkJQdWJsaXNoZXIy ODUzNzk5